Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bioharvest Sciences Inc (CNVCF)

Bioharvest Sciences Inc (CNVCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 98,057
  • Shares Outstanding, K 16,425
  • Annual Sales, $ 12,670 K
  • Annual Income, $ -12,560 K
  • 60-Month Beta N/A
  • Price/Sales 7.95
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CNVCF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.05
  • Most Recent Earnings $-0.35 on 05/30/24
  • Next Earnings Date 08/29/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.6500 +5.66%
on 07/17/24
6.3300 -5.69%
on 07/02/24
+0.0200 (+0.34%)
since 06/18/24
3-Month
0.0011 +99,999.99%
on 06/03/24
7.3800 -19.11%
on 06/10/24
-0.6800 (-10.23%)
since 04/19/24
52-Week
0.0011 +99,999.99%
on 06/03/24
7.7000 -22.47%
on 03/21/24
+0.9300 (+18.45%)
since 07/19/23

Most Recent Stories

More News
BioHarvest Sciences Reports First Quarter 2024 Financial Results

Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 MillionVancouver, British Columbia and Rehovot,...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 millionManagement...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded 50 Ton Manufacturing facility New Production Technologies Implemented...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business UnitVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit

Management Adding Critical Leadership Roles to Support Growth of Recently Launched CDMO Business UnitVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology...

CNVCF : 5.9700 (-2.61%)
BHSC.CN : 8.4000 (unch)

Business Summary

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based...

See More

Key Turning Points

3rd Resistance Point 6.2033
2nd Resistance Point 6.1567
1st Resistance Point 6.0633
Last Price 5.9700
1st Support Level 5.9233
2nd Support Level 5.8767
3rd Support Level 5.7833

See More

52-Week High 7.7000
Last Price 5.9700
Fibonacci 61.8% 4.7590
Fibonacci 50% 3.8505
Fibonacci 38.2% 2.9421
52-Week Low 0.0011

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar